Robert E. Humphreys

3.0k total citations
111 papers, 2.6k citations indexed

About

Robert E. Humphreys is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert E. Humphreys has authored 111 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Immunology, 50 papers in Molecular Biology and 34 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert E. Humphreys's work include Immunotherapy and Immune Responses (34 papers), Monoclonal and Polyclonal Antibodies Research (33 papers) and T-cell and B-cell Immunology (25 papers). Robert E. Humphreys is often cited by papers focused on Immunotherapy and Immune Responses (34 papers), Monoclonal and Polyclonal Antibodies Research (33 papers) and T-cell and B-cell Immunology (25 papers). Robert E. Humphreys collaborates with scholars based in United States, Japan and United Kingdom. Robert E. Humphreys's co-authors include S F Schlossman, Jack L. Strominger, Leonard Chess, Takeshi Sairenji, Masanori Daibata, Minzhen Xu, Edmond J. Yunis, D M Pratt, Robert L. Evans and Victor E. Reyes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.

In The Last Decade

Robert E. Humphreys

110 papers receiving 2.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert E. Humphreys 1.6k 892 699 506 297 111 2.6k
E S Vitetta 2.4k 1.5× 845 0.9× 1.0k 1.4× 365 0.7× 195 0.7× 68 3.2k
Bernardetta Nardelli 1.8k 1.1× 671 0.8× 455 0.7× 500 1.0× 123 0.4× 41 2.8k
F. M. Kourilsky 1.4k 0.9× 866 1.0× 782 1.1× 505 1.0× 130 0.4× 59 2.7k
Robert F. Graziano 1.2k 0.8× 674 0.8× 911 1.3× 735 1.5× 298 1.0× 48 2.4k
Robert W. Karr 3.0k 1.9× 874 1.0× 912 1.3× 299 0.6× 307 1.0× 84 4.3k
C K Goldman 1.6k 1.0× 384 0.4× 358 0.5× 423 0.8× 312 1.1× 18 2.2k
Thi‐Sau Migone 2.4k 1.5× 625 0.7× 611 0.9× 1.0k 2.1× 256 0.9× 40 3.7k
C J Melief 1.8k 1.1× 864 1.0× 318 0.5× 559 1.1× 211 0.7× 41 2.5k
Hinrich P. Hansen 1.5k 1.0× 1.3k 1.5× 353 0.5× 949 1.9× 538 1.8× 72 3.2k
Torsten Dreier 1.0k 0.7× 964 1.1× 1.3k 1.8× 994 2.0× 217 0.7× 38 2.6k

Countries citing papers authored by Robert E. Humphreys

Since Specialization
Citations

This map shows the geographic impact of Robert E. Humphreys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Humphreys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Humphreys more than expected).

Fields of papers citing papers by Robert E. Humphreys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Humphreys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Humphreys. The network helps show where Robert E. Humphreys may publish in the future.

Co-authorship network of co-authors of Robert E. Humphreys

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Humphreys. A scholar is included among the top collaborators of Robert E. Humphreys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Humphreys. Robert E. Humphreys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sotiriadou, Nectaria N., Nikoletta L. Kallinteris, Angelos D. Gritzapis, et al.. (2006). Ii-Key/HER-2/neu(776-90) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumors. Cancer Immunology Immunotherapy. 56(5). 601–613. 44 indexed citations
3.
Kallinteris, Nikoletta L., et al.. (2004). Ii-Key/HER-2/ neu MHC class-II antigenic epitope vaccine peptide for breast cancer. Cancer Immunology Immunotherapy. 53(6). 490–496. 40 indexed citations
4.
Reineke, Ulrich, et al.. (2002). Identification of T helper cell-recognized epitopes in the chitinase of the filarial nematode Onchocerca volvulus. Vaccine. 20(31-32). 3685–3694. 8 indexed citations
5.
Humphreys, Robert E., et al.. (2000). Increasing the potency of MHC class II-presented epitopes by linkage to Ii-Key peptide. Vaccine. 18(24). 2693–2697. 60 indexed citations
6.
Reyes, Vanessa, et al.. (1994). Invariant Chain Dissociation from Class II MHC Is a Catalyst for Foreign Peptide Bindinga. Annals of the New York Academy of Sciences. 730(1). 338–341. 5 indexed citations
7.
Daibata, Masanori, Minzhen Xu, Robert E. Humphreys, & Victor E. Reyes. (1994). More efficient peptide binding to MHC class II molecules during cathepsin B digestion of Ii than after Ii release. Molecular Immunology. 31(4). 255–260. 20 indexed citations
8.
Daibata, Masanori, Robert E. Humphreys, & Takeshi Sairenji. (1992). Phosphorylation of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA. Virology. 188(2). 916–920. 36 indexed citations
9.
Daibata, Masanori, et al.. (1991). Intracellular localization of tyrosine kinase substrates beneath crosslinked surface immunoglobulins in B cells.. The Journal of Experimental Medicine. 174(2). 381–388. 21 indexed citations
10.
Sairenji, Takeshi, Masanori Daibata, Christopher Sorli, et al.. (1991). Relating homology between the Epstein-Barr virus BOLF1 molecule and HLA-DQw8 ? chain to recent onset Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 34(1). 33–39. 12 indexed citations
11.
Bertoni, Giuseppe, et al.. (1990). Synthetic Peptides to Identify Antigenic Determinants on Epstein-Barr Virus gp350/220. Intervirology. 31(5). 290–294. 6 indexed citations
12.
Tiarks, Cheryl Y., Liberto Pechet, & Robert E. Humphreys. (1989). Development of anti‐idiotypic antibodies in a patient with a factor VIII autoantibody. American Journal of Hematology. 32(3). 217–221. 17 indexed citations
13.
Knapp, Walter, et al.. (1989). Inhibition by leupeptin and antipain of the intracellular proteolysis of Ii. Human Immunology. 24(3). 153–163. 59 indexed citations
14.
Thomas, Lawrence J., Quoc Viet Hung Nguyen, William L. Elliott, & Robert E. Humphreys. (1988). Proteolytic cleavage of Ii to p25.. The Journal of Immunology. 140(8). 2670–2674. 24 indexed citations
16.
Sairenji, Takeshi, et al.. (1985). Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.. The Journal of Experimental Medicine. 161(5). 1097–1111. 12 indexed citations
17.
Howe, Rawleigh, et al.. (1979). Internal synthesis of p23,30 by several lymphoid malignancies.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 7(2). 94–104. 4 indexed citations
18.
Evans, Robert L., et al.. (1978). Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens.. The Journal of Experimental Medicine. 148(5). 1440–1445. 322 indexed citations
19.
Humphreys, Robert E., Joseph M. McCune, Leonard Chess, et al.. (1976). Isolation and immunologic characterization of a human. B-lymphocyte-specific, cell surface antigen.. The Journal of Experimental Medicine. 144(1). 98–112. 178 indexed citations
20.
Chess, Leonard, Robert Evans, Robert E. Humphreys, Jack L. Strominger, & S F Schlossman. (1976). Inhibition of antibody-dependent cellular cytotoxicity and immunoglobulin synthesis by an antiserum prepared against a human B-cell Ia-like molecule.. The Journal of Experimental Medicine. 144(1). 113–122. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026